Therefore, investigators used VLPs of human JC polyomavirus (JCPyV) as a vector to carry a newly designed CD59-specific RNA expression plasmid driven by a lung-specific promoter (SP-B) for lung adenocarcinomas (pSPB-shCD59) to specifically inhibit CD59 overexpression in lung cancer cells. Here, CD59 is linked to lung carcinoma.